Eleven (15.7%) ICC had mutations in at least one of mTOR pathway genes: AKT1 (2.8%), PIK3CA (5.7%), PIK3C2A (7.1%), PIK3C2G (4.3%), and PTEN (1.4%). This evidence concerns the gene AKT1 and intrahepatic cholangiocarcinoma.